跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 443 条关于
“Axios”
全部
443
临床试验
375
药物
13
机构
6
资讯
49
上个月
UCB Named a Winner of the 2026 Metro Atlanta Top Workplaces Award Amid $2 Billion Biomanufacturing Expansion
上个月
Colossal Biosciences Eyes $20B–$30B Valuation in New Funding Round, Doubling Prior Worth
2个月前
Long Island Oncology CEO Jeff Vacirca Emerges as FDA Commissioner Candidate Amid Agency Leadership Vacuum
上个月
RFK Jr. Pushes Alzheimer's Screening While USPSTF Remains Paralyzed for Over a Year
去年
FDA Requires Label Update for Agios Pharmaceuticals' Pyrukynd
3年前
Mitapivat Shows Durable Improvements in Thalassemia Patients in Phase 2 Extension Study
2年前
Agios' Tebapivat Receives FDA Orphan Drug Designation for Myelodysplastic Syndromes
4年前
FDA Approves Pyrukynd (mitapivat) for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
去年
Agios Pharmaceuticals Advances Tebapivat for Sickle Cell Disease and Hemolytic Anemias
去年
Agios' Mitapivat Receives Positive CHMP Opinion for Thalassemia Treatment in Europe
第 1 页,共 5 页
上一页
下一页